Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 360

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 10
Chunk 360
---
The
accompanying notes are an integral part of these financial statements

F-3

JUPITER
NEUROSCIENCES, INC.

STATEMENTS
OF OPERATIONS

    December
                                            31, 2024  
    December
                                            31, 2023 

    For
    the Years Ended 

    December
                                            31, 2024  
    December
                                            31, 2023 

    Expenses: 

    Research
    and development 
     492,660  
     954,793 
  
    General
    and administrative 
     2,598,622  
     2,915,978 
  
    Total
    operating expenses 
     3,091,282  
     3,870,771 

    Operating
    loss 
     (3,091,282) 
     (3,870,771)

    Other
    Income (Expenses): 

    Interest
    income 
     5,557  
     482 
  
    (Loss)
    gain on change in fair value of derivative liability 
     (53,257) 
     148,751 
  
    Interest
    expense 
     (248,366) 
     (218,705)
  
    Gain
    (Loss) on extinguishment of debt 
     857,723  
     (887,946)
  
    Other income 
     90,000  
     44,500 
  
    Total
    other income (expenses), net 
     651,657  
     (912,918)

    Net
    loss 
    $(2,439,625) 
    $(4,783,689)

    Net
    loss per common share: 

    Basic 
    $(0.08) 
    $(0.18)
  
    Diluted 
    $(0.08) 
    $(0.18)

    Weighted
    average number of common stock outstanding: 

    Basic 
     28,783,045  
     26,405,109 
  
    Diluted 
     28,783,045  
     26,405,109 

The
accompanying notes are an integral part of these financial statements

F-4

JUPITER
NEUROSCIENCES, INC.

STATEMENTS
OF CHANGES IN STOCK